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A Comparison of Laboratory Automatic Troponin Testing
Versus Point of Care Troponin
Adacilis Ramirez Sardi, Shirley G. Phillip-Samuel, Julie Lamoureux
Introduction
Cardiac Troponin is detected in the blood stream
of patients with myocardial injury using
sensitive and specific assays. The importance of
using a precise assay that can measure Troponin
at a very high percentile with a very low total
imprecision will facilitate the diagnosis of MI on
admission in acute coronary syndrome (ACS)
and other non-STEMIs diagnosis. In this study
we compared two different Troponin
methodologies for validity.

Purpose
The purpose of this study was to demonstrate that
there is no significant difference between the
Emergency Department’s Point of Care (POC)
Troponin test (i-STAT) and the Automated
Laboratory Troponin Analyzers. The goal of the
study was to demonstrate that by using different
methodologies, the presence or absence of a
cardiac event will still be detected.

Methods of Implementation
A secondary analysis of retrospective data for six
months, June 2012-December 2012, was
conducted at a community hospital in Miami,
Florida. The study included 1,567 subjects for
whom Troponin tests were done using both
methodologies on blood samples collected at the
same draw or within 15 minutes of each other (the
first 2 Troponin values for each other).

Figure 1:
Intraclass Correlation Coefficient for Troponin values for the
two methodologies.

Figure 2:
Regression analysis to measure validity of the lab and POC
Troponin methodologies.

Results

Discussion

The exact value of the laboratory and POC Troponin
are not expected to be the same. They are different
methodologies with different calibration. The
manufacturer’s suggested cut-off values to consider
elevated Troponin is 0.06 for the laboratory values
and 0.08 for the POC values. Using the suggested
cut-off scores 99 of the 1,567 subjects (6.3%) had an
elevated laboratory Troponin and 82 of the 1,567
subjects (5.2%) had an elevated POC Troponin.

For the first set of Troponin, the study showed that
both methodologies, POC Troponin and automated
Laboratory Troponin, can be trusted to perform
equally. They both showed low sensitivity and high
specificity in the diagnosing heart events. This
demonstration of high-specificity cardiac Troponin
testing true value will continue to help us in the early
diagnosis of a cardiac event thus facilitating the
speedy treatment of all true cardiac events thereby
improving the patient’s recovery and reduction of
mortality.

 Figure 1 demonstrates that the values of the Lab
Troponins are systematically higher than the POC
Troponin therefore it is not appropriate to compute
an intraclass correlation coefficient (ICC )
between to the two values to estimate reliability.
Instead we used regression analysis and validity
coefficients.
 Figure 2 shows the pairs of Troponin values fall
very close to the regression line between
laboratory and POC Troponin. Overall the
correlation between the two Troponin results was
r = 0.9627 (p < 0.0001).
Depending on the cut-off values for Troponin, the
sensitivity of the tests for detecting subjects with a
principal diagnosis of MI varied between 54% and
64%, the specificity varied between 96% and 98%.

The low sensitivity is probably due in part to the fact
that the measures were only the first Troponin
measurements for a patient. It is recommended to
have serial measurements in patients suspected of
having a heart event.
Nursing care continues to be validated by research
based evidence. It is noteworthy to see that the results
of this research has shown that early detection of
increased Troponin level by a highly specific analysis
on patients presented in the ED with chest pain has a
valuable place in the early treatment of chest pain
thus preventing mortality and decreasing morbidity in
patients with cardiac events.

